{"id":533641,"date":"2021-09-02T07:03:46","date_gmt":"2021-09-02T11:03:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/"},"modified":"2021-09-02T07:03:46","modified_gmt":"2021-09-02T11:03:46","slug":"sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/","title":{"rendered":"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CAMBRIDGE, Mass., Sept.  02, 2021  (GLOBE NEWSWIRE) &#8212; Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics\u2122 platform, today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will participate in two upcoming healthcare investor conferences.<\/p>\n<p align=\"justify\">\n        <strong>Presentation Details:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Event: <\/strong>Morgan Stanley 19<sup>th<\/sup> Annual Global Healthcare Conference<strong><br \/> Date: <\/strong>Friday, September 10, 2021<br \/><strong>Time: <\/strong>8:00 AM ET<strong><br \/> Details: <\/strong>Live Fireside Chat<\/p>\n<p align=\"justify\">\n        <strong>Event: <\/strong>H.C. Wainwright 23<sup>rd<\/sup> Annual Global Investment Conference<br \/><strong>Date: <\/strong>Monday, September 13, 2021<br \/><strong>Time: <\/strong>7:00 AM ET<strong><br \/> Details: <\/strong>On Demand Corporate Presentation<\/p>\n<p align=\"justify\">Webcasts of the Morgan Stanley fireside chat and the H.C. Wainwright corporate presentation will be accessible under \u201cEvents and Presentations\u201d in the Investors &amp; Media page of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-6spHZ9ZJakKnsL_bgXaCtNN3P4m_FHzpqeASbToNLZ88eEzaT_I8yE6PT6hpCyg4wzuxNR7DI4-5ZPLeXDVRQ==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.sigilon.com<\/u><\/a>. A replay of each webcast will be available at the same location following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Sigilon Therapeutics<\/strong><br \/>\n        <br \/> Sigilon Therapeutics seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics\u2122 platform. Sigilon\u2019s product candidates are non-viral engineered cell-based therapies designed to produce the crucial proteins, enzymes or factors needed by patients living with chronic diseases such as hemophilia, lysosomal diseases and diabetes. The engineered cells are protected by Sigilon\u2019s Afibromer\u2122 biomaterials matrix, which shields them from immune rejection and fibrosis. Sigilon was founded by Flagship Pioneering in conjunction with Daniel Anderson, Ph.D., and Robert Langer, Sc.D., of the Massachusetts Institute of Technology.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/> Robert Windsor, Jr., J.D.<br \/> VP, Head of Investor Relations<br \/> Sigilon Therapeutics<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H01D4MTdBMvpKLsYhG4hTRJaC4v8TnIcy2HGmp22itSwSDj2l16B4QkKAht8ifpnhePNPY19QTI_pfAu5qPf_TNQsZZhkuTnfFqS5xyyl9dLx8uVPedx5ICVYGM_cQvY\" rel=\"nofollow noopener\" target=\"_blank\"><u>robert.windsor@sigilon.com<\/u><\/a><br \/>617-586-3837<\/p>\n<p align=\"justify\">\n        <strong>Media Contacts<\/strong><br \/>\n        <br \/> Amy Bonanno<br \/> Solebury Trout<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oZl1ZhCuyN8Toc43hUh46xmdQfN8WsL7QzLgt3nzFlzQG_SBcj-G_tMGimhbwlSsEmdnE7-09BMPS4uaUvuH5GLF4GatCAWM2dcojpfl6_ezt3q5H9pSGXFDIGOXcE1h\" rel=\"nofollow noopener\" target=\"_blank\">abonanno@soleburytrout.com<\/a><br \/> 914-450-0349<\/p>\n<p align=\"justify\">Brandon Hagen<br \/>Manager, Communications<br \/>Sigilon Therapeutics<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IzkfNz1FM4ghv-wmggIbcoe723Knb0HCs8DMqEJ5cfhmHk_2Vyvg5JMYxRHUfpNhCU2SlfjpdWC_kWa9xyjtVbZlvwygBRIgXnIfSie2A9k=\" rel=\"nofollow noopener\" target=\"_blank\">brandon.hagen@sigilon.com<\/a><br \/>617-586-2851<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Mzk0ZTc4OTgtZWMzNy00YWViLWEyM2UtOWFlMDExYTk0YmE2LTExOTI2ODg=\/tiny\/Sigilon-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics\u2122 platform, today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will participate in two upcoming healthcare investor conferences. Presentation Details: Event: Morgan Stanley 19th Annual Global Healthcare Conference Date: Friday, September 10, 2021Time: 8:00 AM ET Details: Live Fireside Chat Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDate: Monday, September 13, 2021Time: 7:00 AM ET Details: On Demand Corporate Presentation Webcasts of the Morgan Stanley fireside chat and the H.C. Wainwright corporate presentation will be accessible under \u201cEvents and Presentations\u201d in the Investors &amp; Media page of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533641","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics\u2122 platform, today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will participate in two upcoming healthcare investor conferences. Presentation Details: Event: Morgan Stanley 19th Annual Global Healthcare Conference Date: Friday, September 10, 2021Time: 8:00 AM ET Details: Live Fireside Chat Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDate: Monday, September 13, 2021Time: 7:00 AM ET Details: On Demand Corporate Presentation Webcasts of the Morgan Stanley fireside chat and the H.C. Wainwright corporate presentation will be accessible under \u201cEvents and Presentations\u201d in the Investors &amp; Media page of the &hellip; Continue reading &quot;Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T11:03:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences\",\"datePublished\":\"2021-09-02T11:03:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/\"},\"wordCount\":285,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/\",\"name\":\"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=\",\"datePublished\":\"2021-09-02T11:03:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics\u2122 platform, today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will participate in two upcoming healthcare investor conferences. Presentation Details: Event: Morgan Stanley 19th Annual Global Healthcare Conference Date: Friday, September 10, 2021Time: 8:00 AM ET Details: Live Fireside Chat Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDate: Monday, September 13, 2021Time: 7:00 AM ET Details: On Demand Corporate Presentation Webcasts of the Morgan Stanley fireside chat and the H.C. Wainwright corporate presentation will be accessible under \u201cEvents and Presentations\u201d in the Investors &amp; Media page of the &hellip; Continue reading \"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T11:03:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences","datePublished":"2021-09-02T11:03:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/"},"wordCount":285,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/","name":"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=","datePublished":"2021-09-02T11:03:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTE2NiM0Mzg1NDI2IzIxODExMTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sigilon-therapeutics-to-participate-in-two-upcoming-healthcare-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sigilon Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533641"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533641\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}